LexisNexis® Legal Newsroom
Merck Wins Defense Verdict In 2nd N.J. Fosamax Jaw Injury Trial

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey state court jury on April 18 returned a defense verdict for Merck, Sharpe & Dohme in a Fosamax jaw injury trial, the company said in a press release ( Jo Ann Sessner v. Merck, Sharpe & Dohme, Inc. , No. ATL-L-3394-11-MT, N.J. Super., Atlantic...

Merck Wins Defense Verdict In 1st Fosamax Femur Case To Go To Verdict

TRENTON, N.J. - (Mealey's) A New Jersey federal jury on April 29 quickly found that Fosamax did not cause a plaintiff's femur fracture, the first verdict in a case in which a plaintiff claims that the osteoporosis drug weakened her thigh bone ( In Re: Fosamax [Alendronate Sodium] Products Liability...